Clinical Trial Update: To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge [Phase 2]

View source ↗

Summary

Phase 2 trial of AL-38583 evaluating reduction of tear eosinophil count after conjunctival allergen challenge has been withdrawn. No efficacy results were repor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• AL-38583

Snippet

Sponsor: Alcon Research | Conditions: Allergic Conjunctivitis | Phase 2 | Status: WITHDRAWN